Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in BRICS has been experiencing significant growth in recent years.
Customer preferences: Customers in the BRICS countries have shown a growing preference for digestive and intestinal remedies available at pharmacies. This can be attributed to several factors, including the increasing awareness about digestive health and the rising incidence of digestive disorders. Consumers are becoming more proactive in managing their health and are seeking over-the-counter remedies to address common digestive issues such as indigestion, bloating, and constipation. The convenience of purchasing these remedies at pharmacies, along with the availability of a wide range of products, has further contributed to the growing preference for this market segment.
Trends in the market: In Brazil, the Digestive & Intestinal Remedies (Pharmacies) market has witnessed a surge in demand due to the country's high prevalence of digestive disorders. The market has been driven by the increasing adoption of self-medication practices and the growing consumer awareness about the importance of digestive health. Additionally, the rising disposable income levels in Brazil have enabled consumers to afford these remedies, further fueling market growth. In Russia, the market for digestive and intestinal remedies has seen steady growth, driven by the increasing incidence of digestive disorders and the rising consumer demand for self-care products. The market has also benefited from the expanding pharmacy retail sector, which provides easy access to these remedies. Furthermore, the Russian population's preference for natural and herbal remedies has led to the introduction of a wide range of organic digestive and intestinal remedies in the market. In India, the Digestive & Intestinal Remedies (Pharmacies) market has witnessed significant growth due to the country's high prevalence of digestive disorders, primarily attributed to dietary habits and lifestyle factors. The market has been further boosted by the increasing consumer awareness about the benefits of preventive healthcare and the availability of a wide range of affordable remedies at pharmacies. The rise of e-commerce platforms has also made these remedies more accessible to consumers across different regions of the country. In China, the market for digestive and intestinal remedies has experienced robust growth due to the increasing consumer awareness about digestive health and the rising prevalence of digestive disorders. The market has been driven by the expanding middle-class population and their willingness to spend on healthcare products. The Chinese government's efforts to promote preventive healthcare and the availability of a wide range of remedies at pharmacies have also contributed to market growth.
Local special circumstances: Each BRICS country has its own unique set of circumstances that influence the Digestive & Intestinal Remedies (Pharmacies) market. In Brazil, the market is influenced by the country's high prevalence of digestive disorders and the increasing disposable income levels. In Russia, the market benefits from the preference for natural and herbal remedies. In India, the market is driven by the high prevalence of digestive disorders and the rise of e-commerce platforms. In China, the market is influenced by the expanding middle-class population and the government's focus on preventive healthcare.
Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies (Pharmacies) market in BRICS can be attributed to several underlying macroeconomic factors. These include the increasing disposable income levels in the BRICS countries, which have enabled consumers to afford these remedies. Additionally, the rising prevalence of digestive disorders and the growing consumer awareness about the importance of digestive health have also contributed to market growth. The expansion of pharmacy retail sectors and the availability of a wide range of products at pharmacies have further fueled market growth in the BRICS countries.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
